Characteristics of psychopathology and the relationship between routes of drug administration and psychiatric symptoms in heroin addicts

Substance Abuse

Volumn 33, Issue 2, 2012, Pages 130-137

  Wang, Qing Liang ^a   Liu, Zhi Min ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Heroin addict; psychiatric symptom; relationship; route of drug administration

Indexed keywords

DIAMORPHINE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CHINA; COMORBIDITY; COMPARATIVE STUDY; DEPRESSION; FEMALE; HEROIN DEPENDENCE; HUMAN; MALE; MENTAL DISEASE; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; SUBSTANCE ABUSE;

ADULT; ANALYSIS OF VARIANCE; CHINA; COMORBIDITY; DEPRESSIVE DISORDER; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HEROIN; HEROIN DEPENDENCE; HUMANS; MALE; MENTAL DISORDERS; PSYCHIATRIC STATUS RATING SCALES; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84859716335     PISSN: 08897077     EISSN: 15470164     Source Type: Journal    
DOI: 10.1080/08897077.2011.630945     Document Type: Article

References (53)

1. The Office of China National Narcotics Control Commission. The number of registered drug users in China, 2009. Available at: http://www.gov.cn/gzdt/2010- 02/01/content 1525435.htm. Accessed June 7, 2010.
2. National Surveillance Center on Drug Abuse. Annual report on drug abuse in China [unpublished]. 2008.
3. Strang J, Griffiths P, Gossop M. Heroin smoking by 'chasing the dragon': origins and history. Addiction. 1997;92:673-683.
4. Thiblin I, Eksborg S, Petersson A, Fugelstad A, Rajs J. Fatal intoxication as a consequence of intranasal administration (snorting) or pulmonary inhalation (smoking) of heroin. Forensic Sci. Int. 2004;139:241-247.
5. Smolka M, Schmidt LG. The influence of heroin dose and route of administration on the severity of the opiate withdrawal syndrome. Addiction. 1999;94:1191-1198.
6. Andersen HS, Sestoft D, Lillebaek T, Gabrielsen G, Hemmingsen R. Heroin dependence: consequences and precursors related to route of administration. Nord J Psychiatry. 1999;53:153-158.
7. Strang J, GossopM, Griffiths P, Farrell M. The technology of dragon chasing. Br J Addict. 1989;84:699.
8. Gossop M, Griffiths P, Strang J. Chasing the dragon: characteristics of heroin chasers. Br J Addict. 1988;83:1159-1162.
9. Grund JP, Blanken P. From chasing the dragon to chinezen: the diffusion of heroin smoking in the Netherlands. Available at: http://www.drugtext.org/ index.php? option=com content&view=category&id=122%3Afromchasing -the -dragon -to -chinezen&Itemid = 5&layout = default&lang=en. Accessed August 18, 2010.
10. Buster M, Rook L, van Brussel GH, van Ree J, van den Brink W. Chasing the dragon, related to the impaired lung function among heroin users. Drug Alcohol Depend. 2002;68:221-228.
11. Hughes S, Calverley PM. Heroin inhalation and asthma. BMJ. 1988;297:1511-1512.
12. Hungerb̈uhler H, Waespe W. Leukoencephalopathy after inhaling "heroin" pyrolysate. Schweiz Med Wochenschrift. 1990;120:1801-1805.
13. Hill MD, Cooper PW, Perry JR. Chasing the dragon-neurological toxicity associated with inhalation of heroin vapour: case report. CMAJ. 2000;162:236-238.
14. Luo WY, Wu J. A case report of heroin spongiform leukoencephalopathy. Chin J Integr Med Cardio/ Cerebrovasc Dis. 2006;4:1031-1032.
15. Jee RC, Tsao WL, Shyu WC, Yen PS, Hsu YH, Liu SH. Heroin vapor inhalation-induced spongiform leukoencephalopathy. J Formosan Med Assoc. 2009;108:518-522.
16. Gossop M, Powis B, Griffiths P, Strang J. Multiple risks for HIV and hepatitis B infection among heroin users. Drug Alcohol Rev. 1994;13:293-300.
17. Crofts N, Hopper JL, Bowden DS, Breschkin AM, Milner R, Locarnini SA. Hepatitis C virus infection among a cohort of Victorian injecting drug users. Med J Aust. 1993;159:237-241.
18. van Beek I, Dwyer R, Dore GJ, Luo K, Kaldor JM. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. BMJ. 1998;317:433-437.
19. Lettington W. Bacteriological skin and subcutaneous infections in injecting heroin users-relevance for custody. J Clin Forensic Med. 2002;9:65-69.
20. Schwartz RH. Adolescent heroin use: a review. Pediatrics. 1998;102:1461-1466.
21. Messinger E. Narcotic septal perforations due to drug addiction. JAMA. 1962;179:964-965.
22. Mitterhofer AP, Antonelli M, Genuini I, Bertazzoni G. High-dose intranasal snorted heroin: a new cause of pancreatitis. Pancreas. 1998;17:213-215.
23. Schoser BG, Groden C. Subacute onset of oculogyric crises and generalized dystonia following intranasal administration of heroin. Addiction. 1999;94:431-434.
24. Downie JB, Dicostanzo DP, Cohen SR. Pemphigus vegetans-Neumann variant associated with intranasal heroin abuse. J Am Acad Dermatol. 1998;39:872-875.
25. Khantzian EJ, Treece C. DSM-III psychiatric diagnosis of narcotic addicts. Recent findings. Arch Gen Psychiatry. 1985;42:1067-1071.
26. Brooner RK, King VL, Kidorf M, Schmidt CW Jr., Bigelow GE. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry. 1997;54:71-80.
27. Frei A, Rehm J. Co-morbidity: psychiatric disorder of opiate addicts at entry into heroin-assisted treatment. Psychiatr Praxis. 2002;29:251-257.
28. Platt JJ, Steer RA, Ranieri WF, Metzger DS. Differences in the Symptom Check List-90 profiles of black and white methadone patients. J Clin Psychol. 1989;45:342-345.
29. Campbell BK, Stark MJ. Psychopathology and personality characteristics in different forms of substance abuse. Int J Addict. 1990;25:1467-1474.
30. Kendall JC, Sherman MF, Bigelow GE. Psychiatric symptoms in polysubstance abusers: relationship to race, sex, and age. Addict Behav. 1995;20:685-690.
31. Wang ZY. The self-report symptom check-list 90 (SCL-90). Shanghai Arch Psychiatry. 1984:68-70.
32. Derogatis LR, Rickels K, Rock AF. The SCL-90 and the MMPI: a step in the validation of a new self-report scale. Br J Psychiatry. 1976;128:280-289.
33. Matti Holi. Assessment of psychiatric symptoms using the SCL-90. Available at: http://ethesis.helsinki.fi/ julkaisut/laa/kliin/vk/holi/assessme. pdf. Accessed June 8, 2011.
34. Chen SL, Li LJ. Re-testing reliability, validity and norm applicability of SCL-90. Chin J Nerv Ment Dis. 2003;29:323-327.
35. Wang JS, Li Y, He ES. Development of SCL-90 in secondary school students. Chin Ment Health J. 1999;13:8-10.
36. Rounsaville BJ, Glazer W, Wilber CH, Weissman MM, Kleber HD. Short-term interpersonal psychotherapy in methadone-maintained opiate addicts. Arch Gen Psychiatry. 1983;40:620-638.
37. Haver B. Screening for psychiatric comorbidity among female alcoholics: the use of a questionnaire (SCL-90) among women early in their treatment programme. Alcohol Alcohol. 1997;32:725-730.
38. Steer RA. Modal profile analyses of the SCL-90 for seven mental disorders. Multivar Exp Clin Res. 1982;6:55-67.
39. Jin H, Wu WY. The preliminary analysis results of SCL-90 assessment in normal Chinese. Chin J Nerv Ment Dis. 1986;12:260-263.
40. Strang J, Des Jarlais DC, Griffiths P, GossopM. The study of transitions in the route of drug use: the route from one route to another. Br J Addict. 1992;87:473-483.
41. Swift W, Maher L, Sunjic S. Transitions between routes of heroin administration: a study of Caucasian and Indochinese heroin users in south-western Sydney Australia. Addiction. 1999;94:71-82.
42. Strang J, Bearn J, Farrell M, et al. Route of drug use and its implications for drug effect, risk of dependence and health consequences. Drug Alcohol Rev. 1998;17:197-211.
43. Michael GW, Hall JN. Heroin users switch from injecting to snorting. Brown Univ Psychopharmacol Update. 1995;6:2-3.
44. Gossop M, Stewart D,Marsden J, Kidd T, Strang J. Changes in route of drug administration among continuing heroin users: outcomes 1 year after intake to treatment. Addict Behav. 2004;29:1085-1094.
45. Chiang SC, Chan HY, Chang YY, Sun HJ, Chen WJ, Chen CK. Psychiatric comorbidity and gender difference among treatment-seeking heroin abusers in Taiwan. Psychiatry Clin Neurosci. 2007;61:105-111.
46. Wu WY. The self-report symptom check-list 90 (SCL-90). In: Zhang ZJ, ed. Handbook of BehavioralMedical Scales. Beijing: Chinese Medical Multimedia Press; 2005:64-67.
47. GossopM, Griffiths P, Powis B, Strang J. Severity of dependence and route of administration of heroin cocaine and amphetamines. Br J Addict. 1992;87:1527-1536.
48. Jenkins AJ, Keenan RM, Henningfield JE, Cone EJ. Pharmacokinetics and pharmacodynamics of smoked heroin. J Anal Toxicol. 1994;18:317-330.
49. Strang J, Griffiths P, Powis B, Gossop M. Heroin chasers and heroin injectors: differences observed in a community sample in London, UK. Am J Addict. 1999;8:148-160.
50. Lima AF, Pechansky F, Fleck MP, De Boni R. Association between psychiatric symptoms and severity of alcohol dependence in a sample of Brazilian men. J Nerv Ment Dis. 2005;193:126-130.
51. Barrio G, De La Fuente L, Lew C, Royuela L, Bravo MJ, Torrens M. Differences in severity of heroin dependence by route of administration: the importance of length of heroin use. Drug Alcohol Depend. 2001;63:169-177.
52. Cone EJ, Holicky BA, Grant TM, Darwin WD, Goldberger BA. Pharmacokinetics and pharmacodynamics of intranasal "snorted" heroin. J Anal Toxicol. 1993;17:327-337.
53. Rajs J, Fugelstad A. Sex cases of sudden death after snorting heroin analyzed. Reduced tolerance in periodic abuse a danger both in snorting and injecting. L̈akartidningen. 2000;97:1834-1835.